|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/29 | |
| A61K 33/10 | |||
| A61P 19/08 | |||
| A61P 19/10 | |||
| A61P 43/00 |
| (11) | Patento numeris | 2682125 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13181715.7 |
| Europos patento paraiškos padavimo data | 2010-09-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 2009208039 | 2009-09-09 | JP |
| (72) |
Shirae, Shinichiro, JP
Nakamura, Yasuo, JP
Oya, Yuiko, JP
Nozaki, Yoshihide, JP
Kobayashi, Nobuyuki, JP
Kuroda, Tatsuhiko, JP
Kato, Hiroki, JP
Serada, Masashi, JP
Hori, Kazuyoshi, JP
|
| (73) |
Asahi Kasei Pharma Corporation,
1-1-2 Yurakucho, Chiyoda-ku Tokyo 100-0006,
JP
|
| (54) | PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK AT UNIT DOSE OF 200 UNITS |
| PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK AT UNIT DOSE OF 200 UNITS |